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ABSTRACT
Background and objective: Because the mortality
and social burden associated with COPD is increasing,
repeated surveys of the prevalence of COPD have been
used to assess risk factors, detect potential patients,
and establish early diagnoses and management proto-
cols. We report the prevalence of spirometrically
detected COPD in Korea in 2008, using data from the
fourth Korean National Health and Nutrition Survey.
Methods: Using nationwide stratified random sam-
pling, based on the Korean Statistical Office census,
6840 subjects aged 19 years underwent spirometry,
which was performed by four trained technicians,
during 2008.The place of residence, levels of education
and income and smoking status, aswell as other results
from a COPD survey questionnaire were also assessed.
Results: Airflow obstruction (FEV1/FVC < 0.7) was
detected in 8.8% of subjects aged 19 years (11.6% of
men and 5.9% of women) and COPD was detected in
13.4% of subjects aged 40 years (19.4% of men and
7.9% of women). Of the 6840 subjects, 27.3% were
current smokers and 17.2% were former smokers, and
the prevalence of COPD was higher in current and
former smokers than in never smokers. Approximately
94% of patients with COPD had mild-to-moderate
disease, without apparent symptoms; only 2.4% had
beendiagnosedbyaphysicianandonly2.1%ofpatients
had been treated. The independent risk factors for
COPDwere smoking, advanced age andmale gender.
Conclusions: Although the prevalence of COPD in
Korea is high, the disease is underdiagnosed and most
COPD patients are under-treated.
Key words: chronic obstructive pulmonary disease,
Korea, prevalence, spirometry, survey.
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SUMMARY AT A GLANCE
A nationwide survey of a Korean population, with
stratified random sampling, revealed that the
prevalence of COPD was high (13.4%) but that
most COPD patients were undiagnosed or under-
treated. This study provides further evidence that
COPD is prevalent but is underdiagnosed and
undertreated.
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INTRODUCTION
COPD is a major disease that is increasing in preva-
lence and mortality, worldwide.1–5 In Korea, it has
been estimated that mortality from COPD will
increase by 30% within 10 years.6 The total hospital-
ization expenses associated with COPD increased
from 111 billion Korean won (USD 110 million) in
2004 to 170 billion won (USD 170 million) in 2007.7 In
addition, COPD ranked 10th among the causes of
death in Korea in 1999 (mortality rate, 13.7 per
100 000 population), and rose to 7th in 2008 (mortal-
ity rate, 14.8 per 100 000 population).6 Therefore, the
burden on national health services due to COPD is
great, and nationwide attention is needed to prevent
COPD and reduce its burden on society.
The worldwide prevalence of COPD has been esti-
mated at 7.5–10%. The prevalence as assessed by pul-
monary function tests (PFT) is higher than that
assessed from patient reports using questionnaires
(9.2% vs 4.9%).8 This discrepancy may be due to the
asymptomatic nature of the disease inmany subjects,
resulting in underdiagnosis by physicians9 and lack of
awareness of COPD as a disease entity.10 Therefore,
PFT are necessary to accurately estimate the preva-
lence of COPD.
Regular spirometric surveys of the population have
enabled the identification of patients withmild COPD
and no or minimal respiratory symptoms, as well as
patients with moderate-to-severe COPD, who have
never been diagnosed by physicians. In addition,
spirometric surveys can be used to determine the risk
factors for COPD and clinical outcomes in patients
with this disease. Spirometric results from the second
Korean National Health and Nutrition Survey
(KNHANES II) indicated that in 2001, the prevalence
of COPD in Korean subjects aged 45 years was
17.2% (men, 25.8%; women, 9.6%).11 Further surveys
on the prevalence of COPD and follow up of these
subjects were not performed until 2007, and the cri-
teria for the standardization of PFT were revised in
2005.12 The Korean Academy of Tuberculosis and Res-
piratory Diseases and the Korea Center for Disease
Control and Prevention conducted a survey on
national health and nutrition, including assessment
of COPD prevalence, beginning in 2007. Here we
report on the prevalence of COPD in Korea in 2008,
using data from the fourth Korean National Health
and Nutrition Survey (KNHANES IV).
METHODS
Study design
During 2008, the second year of KNHANES IV, nation-
wide stratified random sampling was performed
based on data from the Korean Statistical Office
census. The 500 survey areas were drawn from a
census of population and housing by considering the
proportion of each subgroup. Spirometry was per-
formed, and a trained interviewer administered a
questionnaire on respiratory diseases and various
health-related information, including place of resi-
dence, education, income and smoking status. For
spirometric testing, 6840 subjects aged 19 years
from the Korean population were selected. Of these
6840 subjects, 4523 were aged 40 years, and the
prevalence of COPD in this age group was evaluated.
The study was approved by the Institutional
Review Board of the Korea Centers for Disease
Control and Prevention (approval number, 2008-
01EXP-01-C) and informed consent was obtained
from all study participants.
Sampling strategy in the KNHANES IV
For the KNHANES IV, 23 households were sampled
per clustering unit, which consisted of 60~80 house-
holds. Survey clusters were selected in each stratum,
into which the population was divided according to
residential area (rural, urban), type of housing (apart-
ment house, non-apartment house) and population
gender and age structure (child, adult and elderly by
gender). Twenty-three households within a cluster
were selected using a systematic sampling method.
The sample was weighted to adjust for over-sampling,
non-responders and post-stratification.
Spirometry
Spirometry was performed by four technicians, each
of whom underwent two education sessions on PFT
and quality control. Spirometry was performed using
dry rolling seal spirometers (Model 2130; SensorMed-
ics, Yorba Linda, CA, USA) and the American Thoracic
Society/European Respiratory Society criteria for
the standardization of PFT.12 Spirometric prediction
equations were derived from survey data on non-
smokers with normal CXR findings and no history of
respiratory disease or symptoms.10
Spirometric data obtained on site by technicians
were transferred to the review centre on the internet.
Another trained technician assessed whether or not
the data met the criteria for acceptability and repro-
ducibility, and provided quality control feedback to
the technicians, which improved the performance of
spirometry. Data were finally confirmed by the prin-
cipal investigator and saved in the data management
system of the Korea Center for Disease Control and
Prevention.
Questionnaire for COPD survey
Trained interviewers administered the questionnaire
at the time of PFT, to determine whether (i) the
subject had a history of COPD, such as chronic bron-
chitis or emphysema; (ii) had been diagnosed with
COPD by a physician; and (iii) had been treated for
COPD.
Criteria for the assessment of COPD
An FEV1/FVC < 70% was defined as airflow obstruc-
tion in subjects aged 19–39 years, and as COPD in
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subjects aged 40 years. The severity of COPD was
categorized according to the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) criteria,
using data from pre-bronchodilator tests.13 Analyses
were performed only on data that met the following
criteria: (i) 2 acceptable spirometry curves showing
correct starting of the test and expiration for at least
6 s; and (ii) a greatest difference between two mea-
surements of FEV1 or FVC of <150 mL.
Definitions for smoking status, place of
residence and income
Definition of current, former and
never smokers
A never smoker was defined as someone who had
smoked fewer than 100 cigarettes during their life-
time. A smoker was defined as someone who had
smoked 100 cigarettes. Among the latter group,
those who answered in the affirmative to the question
‘Do you currently smoke?’ were defined as current
smokers, whereas thosewho answered in the negative
were defined as former smokers.
Definition of place of residence
In South Korea, the smallest administrative districts
are Dong, Eup and Myeon. Eup and Myeon are the
smallest districts in a rural area, and Dong is the
smallest district in a city. If a subject’s address was
located in a Eup or Myeon, the place of residence was
defined as rural, whereas if the address was in a Dong,
the place of residence was defined as urban.
Definition of income
Income was categorized by ranking according to
gender and age group in 5-year intervals. Each sub-
ject’s income was calculated by dividing the total
household income by the square root of the number
of members in the household.14
Statistical analyses
To estimate representative national health status, we
adjusted for the complex sample design. To adjust for
unequal probabilities of selection, all estimates were
calculated based on sampling weights for sample
area, household selection rate, and sample household
and response rate of the subjects. These weighted
values were adjusted for gender and age using post-
hoc analysis, to produce results that were representa-
tive of the entire Korean population.
Sample design and sampling weights were deter-
mined using the SURVEY PROCEDURE in SAS 9.1.3
(SAS Institute Inc., Cary, NC, USA). The prevalence
of COPD was determined using the SURVEYFREQ
procedure (SAS Institute Inc.). Comparisons between
performance and non-performance of spirometry,
and between satisfactory and unsatisfactory accept-
ability and reproducibility of spirometry were tested
using the chi-square test. Data were expressed as
means  SEM.
RESULTS
A total of 6840 subjects aged 19 years (mean age,
49.0  0.5 years) were identified. Of these, 4523
(41.7% male; 58.3% female) were aged 40 years
(mean age, 58.4  0.3 years; men, 57.6  0.3 years;
women, 58.9  0.4 years). Of these 4523 subjects,
99.6% completed the questionnaire and 92.1% (4166)
underwent spirometry, whereas 7.9% refused spirom-
etry. Of the 4166 subjects who performed spirometry,
acceptability and reproducibility criteria were satis-
fied for 2501 (60.0%) (Fig. 1). The proportion of PFT
results that satisfied the criteria for acceptability
and reproducibility decreased significantly with age
(P < 0.001), but was not related to gender, residential
area or income.
Overall prevalence and severity of COPD
Of the subjects aged 19 years who satisfied the cri-
teria for acceptability and reproducibility of spirom-
etry, 8.8% (SEM 0.6) had airflow obstruction (11.6%
(0.9) of men and 5.9% (0.6) of women). Of the 2501
subjects aged 40 years who satisfied the criteria for
acceptability and reproducibility of spirometry, 13.4%
(0.9) had COPD (19.4% (1.5) of men and 7.9% (0.1) of
women) (Table 1). The prevalence of COPD was
significantly higher in men than in women and
increased with age (Fig. 2). Of the subjects diagnosed
with COPD, the severity of disease was GOLD stage I
or II in 94% (Fig. 3).
Risk factors for COPD
Of the 2501 subjects aged 40 years, 22.9% (41.8%
men) were current smokers and 21.3% (41.2% men)
were former smokers (Table 2). The overall prevalence
of COPD was significantly higher in former and
current smokers than in never smokers (Table 3).Mul-
tivariate analysis showed that age 65 years, male
gender, low income and smoking status were signifi-
cant independent risk factors for COPD (Table 3).
Awareness of COPD
Of the 354 subjects who were confirmed as having
COPD, 353 completed the questionnaire. Of these
subjects, nine (2.4%) reported having been diagnosed
with COPD by a physician and eight (2.1%) reported
having been treated.
DISCUSSION
In the KNHANES IV, the prevalence of COPD was
13.4% among subjects aged40 years (19.4% of men,
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7.9% of women). The overall worldwide prevalence of
COPD has been reported to be 7.5–10%,8 suggesting
that the prevalence of COPD is higher in Korea. The
prevalence of COPD in the KNHANES II, performed in
2001, was 17.2%.11 The discrepancy in the prevalence
of COPD between KNHANES II and IV may be attrib-
uted to differences in the reproducibility criteria
for quality control of PFT rather than to an actual
decrease in the prevalence of COPD.
In KNHANES II, data from subjects with at least two
acceptable spirometry curves were analysed, whereas
in KNHANES IV, data were only analysed if there were
at least two acceptable spirometry curves and the
data were also reproducible (largest and second
largest FEV1 and FVC determinations within 150 mL
of each other). In KNHANES IV, 75.2% of the subjects
who performed spirometry had at least two accept-
able spirometry curves (the criterion in KNHANES II)
and 60.0% had at least two acceptable spirometry
curves with reproducible data (the criteria in
KNHANES IV). The frequency of unsatisfactory
spirometry curves increased with age (P < 0.001).
Elderly subjects, among whom there would be a high
prevalence of COPD, were underrepresented in the
KNHANES IV analysis, whichmay have resulted in the
reporting of a lower overall prevalence of COPD in
KNHANES IV compared with KNHANES II. When
re-calculated by applying the same criteria used
in KNHANES II (subjects aged45 years with at least
two acceptable spirometry curves without any repro-
ducibility criteria), the prevalence of COPD in the
present population was 17.7% (28.2% in men; 9.3% in
women), which was similar to the prevalence
reported in KNHANES II (17.2%).
The annual decline in FEV1 has been shown to be
greater in COPD patients than in healthy subjects.15,16
As the severity of COPD increases, so does the fre-
quency of hospitalization and the mortality rate,
which in turn results in an increase in medical
expenses. COPD patients with severe pulmonary dys-
function have a 9.5-fold higher rate of hospitaliza-
tion17 and a 2.7-fold higher rate of mortality than
subjects without COPD.18 Therefore, a reduction in
the annual decline in FEV1 is of crucial importance
in the treatment of COPD. However, there are no
effective treatments that reduce the annual decline in
FEV1, although several large prospective studies have
reported that early treatment of patients with mild-
to-moderate COPD can reduce mortality and the
annual decline in FEV1.19–21 Therefore, it is important
to identify patients with early-stage COPD (mild or no
symptoms) and to provide them with appropriate
treatment.
Of the subjects diagnosed with COPD, 94% had
mild-to-moderate COPD (early-stage COPD) accord-
ing to the GOLD criteria, which was similar to the
result from KNHANES II (95%). Patients with mild-to-
moderate COPD usually do not visit a clinic, due to
the absence of clinical symptoms such as cough and
dyspnoea, and they are therefore often not diagnosed
with COPD.8 Even subjects who have been diagnosed,
however, do not receive adequate long-term treat-
ment.22,23 Indeed, the present data showed that only
2.1% of the subjects diagnosed with COPD received
treatment.
Smoking is the most common cause of COPD.
Among the subjects surveyed in KNHANES II, who
were aged 45 years, 27.5% were current smokers
and 12.7% were former smokers. In comparison,
among subjects aged 45 years surveyed in
KNHANES IV, 21.4% (38.9% male) were current
smokers and 22.3% (43.7% male) were former
smokers. In smokers, the annual decline in FEV1 is
more rapid,15 whereas early smoking cessation may
slow the annual rate of decline in FEV1.24–26 Based on
these results, smoking cessation should be the first
step in preventing the development of COPD.
Subjects aged ≥19 years
n = 6 840
Subjects aged ≥40 years
n = 4 523
Subjects undergoing
spirometry
n = 4 166
Subjects having
acceptable and
reproducible spirometry
n = 2 501 (60.0%)
Subjects who have COPD
n = 354
Subjects having at least one
curve of acceptable criteria
n = 3 522 (84.5%)
Figure 1 Selection of subjects for analysis of the preva-
lence of COPD. The numbers of subjects as percentages
of those who underwent spirometry are indicated in
parentheses.
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Estimates of the prevalence of COPD are usually
lower when based on questionnaire surveys only,
compared with those that use PFT. A meta-analysis of
62 studies from 28 countries reported that the preva-
lence of COPD was 9.2% in surveys that used PFT, but
only 4.9% in surveys that used questionnaires alone.8
Estimation of the prevalence of COPD by question-
naires may be confounded by various factors.9
Because the prevalence of COPD is about twice as
high in surveys using PFT compared with those using
questionnaires, surveys of the prevalence of COPD
should include PFT.
With regard to all characteristics except age, sub-
jects who satisfied the requirements for acceptability
and reproducibility of spirometry did not differ sig-
nificantly from those who did not satisfy the require-
ments. The age distribution of the subjects who
satisfied the requirements was similar to that of all
subjects who underwent spirometry. Therefore, the
subjects who satisfied the requirements can be con-
sidered to be representative of the total population.
This survey had several strengths, including the use
of a perennial survey system, thus minimizing sea-
sonal and regional variations. Second, the values
obtained from the survey were representative of those
Table 1 Prevalence of airflow obstruction stratified by place of residence, education and income
Total population Men Women
Number of
subjects
Prevalence
%
Number of
subjects
Prevalence
%
Number of
subjects
Prevalence
%
Age
19 years 3435 8.8 1478 11.6 1957 5.9
40 years 2501 13.4 1056 19.4 1445 7.9
Place of residence
Rural 1741 12.2 730 17.4 1011 7.5
Urban 760 17.8 326 25.9 434 9.5
Education
Elementary school or lower 957 21.2 275 38.6 682 12.7
Middle school 423 15.1 201 22.7 222 6.4
High school 712 7.0 318 11.4 394 2.6
College or higher 401 8.5 256 10.2 145 5.3
Income
Low 561 14.6 221 20.6 340 9.2
Low ~ middle 596 13.2 257 19.7 339 7.0
Middle ~ high 629 11.8 281 17.7 348 5.8
High 642 10.7 267 15.6 375 6.6
Figure 2 Prevalence of airflow obstruction stratified
according to age groups. ( ) 40–49 years; ( )
50–59 years; ( ) 60–69 years; ( ) 70 years.
Figure 3 Prevalence of airflow obstruction among sub-
jects older than 40 years, stratified according to GOLD
classification. I, II, III and IV indicate the GOLD stages of
increasing severity of COPD. GOLD, Global Initiative for
Chronic Obstructive Lung Disease.
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for theKoreanpopulation, followingpost-hocanalysis
according to age and gender. Third, technical and per-
sonal errors were minimized by the use of criteria for
both acceptability and reproducibility of spirometry.
This survey also had several limitations. First, CXR
were not obtained for the study participants. As dis-
eases other than COPD, such as bronchiectasis and
pulmonary tuberculosis, may cause airflow obstruc-
tion, the true prevalence of COPD may have been
lower. However, KNHANES II indicated that there was
no significant difference in the prevalence of COPD
between subjects who did or did not undergo CXR.
Second, a fixed FEV1/FVC ratio was used to define
airflow obstruction, without consideration of the
decrease in pulmonary function with age. Thus,
the data that were analysed were obtained from
pre-bronchodilator PFT, while the prevalence of
COPD in elderly subjects appeared to be overesti-
mated.27,28 Third, pre-bronchodilator testing was used
for the diagnosis of COPD,13 which may have resulted
in the inclusion of asthmatic patients and overestima-
tion of the prevalence of COPD.29,30 Therefore, to accu-
rately determine the prevalence of COPD, post-
bronchodilator PFT results should be used. However,
recommended testing procedures differ in the US
NHANES (2008),31 GOLD,13 and American Thoracic
Society/European Respiratory Society guidelines.12
Fourth, the proportion of subjects with acceptable
and reproducible spirometry was rather low (60%).
Therefore, the characteristics of subjects who did or
did not satisfy the criteria for acceptability and repro-
ducibility were compared and no differences were
found, except for age.
In this survey, the prevalence of COPD in subjects
aged >40 years was 13.4%, with >90% having mild
disease. A considerable number of subjects had not
been diagnosed with COPD, and many subjects who
were diagnosed with COPD did not receive appropri-
ate treatment. By the use of spirometry, patients with
mild, as well as moderate-to-severe COPD, who had
not been diagnosed, were identified. These surveys
should be continued to determine and reduce risk
factors until the prevalence and social burden of
COPD has decreased sufficiently. A fifth survey
(KNHANES V) is presently being conducted, using
new criteria for spirometric testing that require at
Table 2 Percentage of smokers stratified by age and gender
Smoking status
Total population (%) Men (%) Women (%)
>19 years >40 years >19 years >40 years >19 years >40 years
Current 27.3 22.9 47.7 41.8 7.3 5.5
Former 17.2 21.3 30.5 41.2 4.2 3.0
Never 55.5 55.7 21.8 17.0 88.5 91.5
Table 3 Univariate and multiple logistic regression analyses assessing the risk factors for COPD
n %
Univariate analysis Multivariate analysis
OR P-value 95% CI OR P-value 95% CI
Age, years
<65 1812 8.0 Reference — — Reference — —
65 689 31.1 1.45 >0.05 0.88–2.37 1.78 <0.05 1.01–3.17
Gender
Female 1445 7.9 Reference — — Reference — —
Male 1056 19.4 4.01 <0.001 2.84–5.68 3.07 <0.001 1.90–4.97
Place of residence
Rural 1741 12.2 Reference — — Reference — —
Urban 760 17.8 1.30 >0.05 0.95–1.77 1.18 >0.05 0.85–1.63
Education
Elementary 957 21.2 Reference — — Reference — —
College or higher 401 8.5 0.96 >0.05 0.52–1.76 0.60 >0.05 0.30–1.20
Income
Low 561 14.6 Reference — — Reference — —
Low ~ middle 596 13.2 0.85 >0.05 0.57–1.28 0.89 >0.05 0.58–1.38
Middle ~ high 629 11.8 0.73 >0.05 0.47–1.13 0.86 >0.05 0.54–1.36
High 642 10.7 0.61 <0.05 0.39–0.96 0.87 >0.05 0.54–1.39
Smoking
Never 1506 7.7 Reference — — Reference — —
Former 501 17.7 2.48 <0.001 1.66–3.64 1.28 >0.05 0.77–2.11
Current 485 22.9 5.41 <0.001 3.64–8.05 2.80 <0.001 1.76–4.45
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least three acceptable curves, as well as reproducibil-
ity. By including the use of bronchodilator(s) and
defining airflow obstruction relative to the lower
limits of normal, KNHANESV is expected to provide a
more accurate estimate of the prevalence of COPD in
Korea.
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